Identifying the Stakeholders Vital to Clinical Trial Success

Photo by Pavel Danilyuk on Pexels.com

Health systems are not static; they transform with new financial pressures, market trends, care delivery models, and technological advancements. At Petauri Kinect, we believe that pharmaceutical and biotechnology companies should align trial strategies with a deep understanding of health system stakeholder engagement, infrastructure, enrollment & referral patterns, and education.   There has never been a more… Continue reading Identifying the Stakeholders Vital to Clinical Trial Success

Understanding the Health System Dynamics Impacting Clinical Trials 

Photo by Artem Podrez on Pexels.com

Clinical trials are a foundational element of the US healthcare system. According to the National Library of Medicine, the number of registered clinical trial studies worldwide surged at a compound annual growth rate of approximately 27% from 2000 to 2023.1 The dramatic increase underscores a trial’s role in advancing health and science–from discovering new treatments… Continue reading Understanding the Health System Dynamics Impacting Clinical Trials 

Alyssa Schatz from National Comprehensive Cancer Network® (NCCN®) Featured on TKG Healthcare Insights Podcast

TKG’s Healthcare Insights podcast hosted by vice president Warren Smedley recently spoke with Alyssa Schatz, senior director, policy and advocacy at the National Comprehensive Cancer Network® (NCCN®) about the organization’s strategic priorities.